Jun
2026
Shanghai New International Expo Center
Visit us
stand W1E40a, Pharma Ingredients

Nantong Jinghua Pharmaceutical Co., Ltd.

Exhibitor at CPHI & PMEC China 2026
About Us

Nantong Jinghua Pharmaceutical Co.,Ltd is a GMP pharmaceutical company focus on R&D, manufacture and sales of APIs & intermediates. Our product Primidone, Fluorouracil, Flucytosine,Phenobarbital, Phenylbutazone,Propylthiouracil have got CEPs and also we have been inspected by FDA, TGA,cofepris and ANVISA. We have a long and stable corporation with many world-famous pharmaceutical companies, like Sanofi, Novartis.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +86 513 85609405
  • Website
  • No.20, 3 Haibin Road, Yanhai, Yanhai Economic Development Zone, Rudong, 226407, Nantong, Jiangsu, China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W1E40a, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • Letermovir

    Product Letermovir

    use in prophylaxis of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplant patients. It is the first of a new class of CMV anti-infectives called DNA terminase complex inhibitors. 
  • INDOCYANINE GREEN

    Product INDOCYANINE GREEN

    Indocyanine green is a Diagnostic Dye. The mechanism of action of indocyanine green is as a Dye.
  • Phenobarbital

    Product Phenobarbital

    There are CEP and US DMF for this product, our main markets are regulatory market, such South America and European.
  • Fluorouracil

    Product Fluorouracil

    There are CEP certificate and US DMF, approved by TGA, FDA and COFERPIS.
  • Phenylbutazone

    Product Phenylbutazone

    There are CEP certificate and US VMF, approved by FDA for more than three years. Our main markets are European and US.